Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Nitroscanate
Chanelle Pharmaceuticals Manufacturing Limited
QP52AX01
Nitroscanate
100 mg/tablet
Film-coated tablet
CAM: Companion Animal Medicine as defined in relevant national legislation
nitroscanate
Authorised
1994-02-10
Health Products Regulatory Authority 05 January 2022 CRN00CGN6 Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Troscan 100 mg film coated tablet for Dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION EACH TABLET CONTAINS: ACTIVE SUBSTANCE: Nitroscanate 100 mg EXCIPIENT(S): Titanium Dioxide (E171) 0.778 mg Iron Oxide Yellow (E172) 0.0257 mg Iron Oxide Black (E172) 0.00003 mg Iron Oxide Red (E172) 0.00003 mg For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film coated tablet. Yellow film coated round convex tablet. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES The product is a broad spectrum anthelmintic for use in puppies and adult dogs for the treatment of infection by adult intestinal nematodes or cestodes of the following species: Nematodes: _Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Uncinaria stenocephala_ Cestodes: _Taenia hydatigena, Taenia pisiformis, Dipylidium caninum_ 4.3 CONTRAINDICATIONS Do not administer to sick or convalescing animals. Do not use in puppies of less than 3 weeks of age. Do not use in cases of hepatic dysfunction. Do not use in cases of known hypersensitivity to the active substance. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The product is not indicated for the treatment of _Trichuris vulpis _andgives only a limited level of control of _Echinococcus _ _granulosus._ Since the most common tapeworm of the dog (_Dipylidium caninum_) is transmitted by a flea and has a very short pre-patent period, it is important to pay attention to flea control to reduce the incidence of tapeworm in the animal. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Do not repeat treatment if vomiting occurs shortly after dosing In order to minimise the risk of vomiting, administer with food (See section 4.9) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMIN Read the complete document